We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
GT Biopharma Inc | NASDAQ:GTBP | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0472 | -1.52% | 3.06 | 3.01 | 3.11 | 3.06 | 3.06 | 3.06 | 72 | 14:39:39 |
BEVERLY HILLS, Calif., June 16, 2021 /PRNewswire/ -- GT Biopharma, Inc. ("GT Biopharma" or the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager (TriKE™) protein biologic technology platform, today announced that it will provide a corporate update at the upcoming Raymond James Human Health Innovation Conference on Tuesday, June 22, 2021 at 11:20 AM ET.
A live webcast of the event will be available by visiting "Presentations" page in the Investors section of GT Biopharma's website at www.gtbiopharma.com/news-media/presentations. A replay of the webcast will be archived for 30 days following the presentation.
About GT Biopharma, Inc.
GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based on our proprietary TriKE™ NK cell engager platform. Our TriKE™ platform is designed to harness and enhance the cancer killing abilities of a patient's immune system's natural killer cells (NK cells). GT Biopharma has an exclusive worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE™ technology. For more information, please visit gtbiopharma.com.
Investor Contact: | Investor and Media Relations Contact: |
Brendan Payne | David Castaneda |
Client Lead | David@gtbiopharma.com |
Stern Investor Relations, Inc. | 414-351-9758 |
brendan.payne@sternir.com | |
212-362-1200 |
View original content:http://www.prnewswire.com/news-releases/gt-biopharma-to-present-at-raymond-james-human-health-innovation-conference-301313508.html
SOURCE GT Biopharma, Inc.
Copyright 2021 PR Newswire
1 Year GT Biopharma Chart |
1 Month GT Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions